PARADIGM-SHIFT predicts the function of mutations in multiple cancers using pathway impact analysis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 22962493.
- Also identified by DOI 10.1093/bioinformatics/bts402 and PMC identifier 3436829.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
A current challenge in understanding cancer processes is to pinpoint which mutations influence the onset and progression of disease. Toward this goal, we describe a method called PARADIGM-SHIFT that can predict whether a mutational event is neutral, gain-or loss-of-function in a tumor sample. The method uses a belief-propagation algorithm to infer gene activity from gene expression and copy number data in the context of a set of pathway interactions. The method was found to be both sensitive and specific on a set of positive and negative controls for multiple cancers for which pathway information was available. Application to the Cancer Genome Atlas glioblastoma, ovarian and lung squamous cancer datasets revealed several novel mutations with predicted high impact including several genes mutated at low frequency suggesting the approach will be complementary to current approaches that rely on the prevalence of events to reach statistical significance. All source code is available at the github repository http:github.org/paradigmshift. jstuart@soe.ucsc.edu Supplementary data are available at Bioinformatics online.
Medical subject headings
- Algorithms
- Mutation
- Neoplasms